Skip to main content
New Business Development

Startup Consulting for Pharma & Nutraceutical Manufacturing

Startup support for companies entering pharma or nutraceutical manufacturing.

Overview

What this covers

The expensive mistakes in this sector are made early and on paper: a product mix that needs three incompatible lines, equipment bought before the room that has to hold it exists, a compliance burden discovered after the lease is signed.

This engagement works the whole path through before capital is committed - what to make, what it takes to make it, what the facility and compliance load actually looks like, and in what order to build it.

For companies entering pharmaceutical or nutraceutical manufacturing, we work through the whole path: what product lines make sense, what equipment they require, what the facility and compliance burden looks like, and what it costs before you commit capital. Covers tablet, capsule, blending and mixing, and coating lines - with a realistic sequence for standing them up.

Included capabilities

  • 01Market and product line assessment
  • 02Tablet and capsule line planning
  • 03Blending & mixing line planning
  • 04Coating line planning
  • 05Capital and compliance roadmap

Who this is for

  • Brands moving from contract manufacturing to their own facility
  • Investors and founders assessing an entry into the sector
  • Existing manufacturers adding a dosage form or a new line
  • Companies that need a realistic capital number before committing
Deliverables

What you actually receive

Documents and outcomes, not hours. Each item is something you can hand to an inspector, a supplier or your own team.

  • 01

    Product line assessment

    Which dosage forms make sense given the target market, and which combinations share equipment rather than competing for it.

  • 02

    Line and equipment plan

    Tablet, capsule, blending and mixing and coating lines scoped with capacity, footprint and utility requirements.

  • 03

    Facility and compliance load

    The classified space, controls and documentation system the chosen products require, and the staffing it implies.

  • 04

    Capital and sequencing roadmap

    What is bought and built in what order, so the first saleable batch does not wait on the last purchase.

How it runs

The sequence for this engagement

  1. 01

    Commercial intent

    Target products, volumes and markets, and whether the plan is own-brand, contract manufacturing or both.

  2. 02

    Technical feasibility

    What each product requires in process, equipment and classified space - and where those overlap.

  3. 03

    Capital and compliance model

    Equipment and fit-out cost against the regulatory burden, with the staffing and SOP load made explicit.

  4. 04

    Build sequence

    A phased plan that gets one line validated and earning before the next is committed.

Common questions

New Business Development questions

What does it take to start manufacturing supplements in-house?
At minimum: a facility with appropriately controlled and separated space, the equipment for your chosen dosage forms, a documented quality system with SOPs and batch records, trained staff, and validated processes. This engagement quantifies each of those for your specific product mix before capital is committed.
Is it cheaper to use a contract manufacturer or build our own line?
It depends on volume, margin and how much control the product needs. Contract manufacturing avoids capital and compliance overhead but caps margin and flexibility. The assessment gives you the crossover point for your own numbers rather than a general rule.
Which lines do you plan?
Tablet, two-piece capsule, blending and mixing, and coating lines - the same forms covered by the formulation and equipment services, so the plan is built by people who will also implement it.
Related services

Free initial consultation

Need new business development?

Describe the facility, product or line and you will get a direct technical answer from Mohammed Z. Rahman, GMP Auditor.